Join to view full profile
12902 Usf Magnolia DrTampa, FL 33612
Phone+1 813-745-7365
Fax+1 813-449-8618
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 11 invites waiting! - Read the latest clinical news, personalized to your specialty.
Education & Training
University of Naples Faculty of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2023 - 2028
IN State Medical License 2020 - 2027
Publications & Presentations
PubMed
- Chronic graft vs. host disease following post-transplant cyclophosphamide (PTCy) based prophylaxis vs. non-PTCy prophylaxis.Joseph A Pidala, Jongphil Kim, Jose Laborde, Samantha Knott, Krishnakar Mogili
Blood Advances. 2026-07-21 - A novel severe toxicity-free, and progression-free survival endpoint predicts outcomes after CD19 chimeric antigen receptor-T cell therapy in large B-cell lymphoma.Aditi Saha, Junmin Whiting, Razan Mohty, Kristen Flores, Jongphil Kim
Bone Marrow Transplantation. 2026-07-17 - Patient-reported outcomes after idecabtagene vicleucel vs. ciltacabtagene autoleucel CAR-T for multiple myeloma.Laura B Oswald, Xiaoyin Li, Lisa M Gudenkauf, Gabe De Avila, David Scheiber-Camoretti
Bone Marrow Transplantation. 2026-07-01
Press Mentions
Healthcare Triage Podcast: Making Progress in Multiple Myeloma Research | the Incidental EconomistMarch 26th, 2021- Leukemia Research Foundation Awards $1.3 Million in GrantsAugust 28th, 2020
Grant Support
- Identifying cell surface targets for innovative immunotherapy of Multiple MyelomaH. LEE MOFFITT CANCER CTR & RES INST2024–2029
- Alternatively spliced cell surface proteins as drivers of leukemogenesis and targets for immunotherapyH. LEE MOFFITT CANCER CTR & RES INST2023–2025
